Diseases, Conditions, Syndromes

Study shows high frequency of spontaneous mutation in Ebola virus

In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat ...

Diseases, Conditions, Syndromes

SARS-CoV-2 following predictable mutational footsteps

New research from the University of Nebraska–Lincoln has shown that the mutations arising in the COVID-19-causing SARS-CoV-2 virus seem to run in the family—or at least the genus of coronaviruses most dangerous to humans.

Diseases, Conditions, Syndromes

Study tracks evolution of SARS-CoV-2 virus mutations

Since COVID-19 began its menacing march across Wuhan, China, in December 2019, and then across the world, the SARS-CoV-2 virus has taken a "whatever works" strategy to ensure its replication and spread. But in anew study ...

Diseases, Conditions, Syndromes

Flu's response to new drug explored

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018. Scientists from EMBL Grenoble have now investigated the drug's mode of action ...

page 13 from 23